Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0T2ZQ
|
||||
| Former ID |
DIB012892
|
||||
| Drug Name |
Felbinac prodrug
|
||||
| Synonyms |
Daitac; Napageln; Seltouch; BPAA acyl ester; Felbinac prodrug (liposomal); LM-001; Lipo-BPAA; Felbinac prodrug (liposomal), Lederle
|
||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Preclinical | [1] | ||
| Company |
Wyeth KK
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
C(=O)(Cc1ccc(c2ccccc2)cc1)OCC
|
||||
| CAS Number |
CAS 14062-23-8
|
||||
| Target and Pathway | |||||
| Target(s) | Cyclooxygenase | Target Info | Modulator | [2], [3] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008689) | ||||
| REF 2 | Predicting Cyclooxygenase Inhibition by Three??imensional Pharmacophoric Profiling. Part I: Model Generation, Validation and Applicability in Ethnopharmacology. Molecular Informatics 01/2010; 29(1??):75 - 86. | ||||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.